Growth Metrics

Axogen (AXGN) Other financing activities (2010 - 2026)

Axogen's quarterly Other financing activities came in at $792000.0 in Q1 2026, up 171.23% quarter-over-quarter from $292000.0 in Q3 2020.

Axogen has reported Other financing activities for 7 years, with the latest figure at $792000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $792000.0; the trailing twelve-month figure through Mar 2026 stood at $792000.0 (changed N/A YoY), and the FY2020 full-year result was $642000.0, changed N/A from the prior year.
  • Other financing activities for Q1 2026 stood at $792000.0, up from $292000.0 in the prior quarter.
  • The five-year high for Other financing activities was $792000.0 in Q1 2026, with the low at $792000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Axogen 2.00 Bn 1.90 Bn 46.19 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 792,000.00
Mar 31, 2026 792,000.00
Sep 30, 2020 292,000.00
Sep 30, 2020 292,000.00
Dec 31, 2017 198,528.00
Dec 31, 2017 198,528.00
Jun 30, 2017 3,043.00
Jun 30, 2017 3,043.00
Mar 31, 2017 26,429.00
Mar 31, 2017 26,429.00
Dec 31, 2015 -3.00
Dec 31, 2015 -3.00
Mar 31, 2015 180,142.00
Mar 31, 2015 180,142.00
Dec 31, 2012 1.19 Mn
Dec 31, 2012 1.19 Mn
Sep 30, 2012 101,775.00
Sep 30, 2012 101,775.00
Dec 31, 2011 132,994.00
Dec 31, 2011 132,994.00
Sep 30, 2011 219,432.00
Sep 30, 2011 219,432.00
Jun 30, 2011 45,000.00
Jun 30, 2011 45,000.00
Mar 31, 2011 37,346.00
Mar 31, 2011 37,346.00
Dec 31, 2010 53,930.00
Dec 31, 2010 53,930.00